BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36533707)

  • 1. The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
    Hoxhaj A; Drissen MMCM; Vos JR; Bult P; Mann RM; Hoogerbrugge N
    Cancer; 2022 Aug; 128(15):2883-2891. PubMed ID: 36533707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor Syndrome.
    Kwinten KJJ; Drissen MMCM; de Hullu JA; Vos JR; Hoogerbrugge N; van Altena AM
    Eur J Med Genet; 2023 Jul; 66(7):104785. PubMed ID: 37172779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.
    Brewer T; Yehia L; Bazeley P; Eng C
    Am J Hum Genet; 2022 Aug; 109(8):1520-1533. PubMed ID: 35931053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
    Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
    Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
    Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
    Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes.
    Kurek KC; Howard E; Tennant LB; Upton J; Alomari AI; Burrows PE; Chalache K; Harris DJ; Trenor CC; Eng C; Fishman SJ; Mulliken JB; Perez-Atayde AR; Kozakewich HP
    Am J Surg Pathol; 2012 May; 36(5):671-87. PubMed ID: 22446940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
    Hendricks LAJ; Hoogerbrugge N; Mensenkamp AR; Brunet J; Lleuger-Pujol R; Høberg-Vetti H; Tveit Haavind M; Innella G; Turchetti D; Aretz S; Spier I; Tischkowitz M; Jahn A; Links TP; Olderode-Berends MJW; Blatnik A; Leter EM; Evans DG; Woodward ER; Steinke-Lange V; Anastasiadou VC; Colas C; Villy MC; Benusiglio PR; Gerasimenko A; Barili V; Branchaud M; Houdayer C; Tesi B; Yazicioglu MO; van der Post RS; Schuurs-Hoeijmakers JHM; ; Vos JR
    J Natl Cancer Inst; 2023 Jan; 115(1):93-103. PubMed ID: 36171661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients.
    Pena-Couso L; Ercibengoa M; Mercadillo F; Gómez-Sánchez D; Inglada-Pérez L; Santos M; Lanillos J; Gutiérrez-Abad D; Hernández A; Carbonell P; Letón R; Robledo M; Rodríguez-Antona C; Perea J; Urioste M;
    Orphanet J Rare Dis; 2022 Feb; 17(1):85. PubMed ID: 35227301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and yield of thyroid cancer surveillance in adults with PTEN hamartoma tumour syndrome.
    Drissen MMCM; Vos JR; Netea-Maier RT; Gotthardt M; Hoogerbrugge N
    Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37451289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating somatic CNV and gene expression in breast cancers from women with PTEN hamartoma tumor syndrome.
    Brewer T; Yehia L; Bazeley P; Eng C
    NPJ Genom Med; 2023 Jul; 8(1):14. PubMed ID: 37407629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
    Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
    J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Progression of Thyroid Disease in
    Plitt G; Brewer T; Yehia L; Jin J; Shin J; Eng C
    Thyroid; 2022 Sep; 32(9):1094-1100. PubMed ID: 35761794
    [No Abstract]   [Full Text] [Related]  

  • 16. PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female.
    Ramkumar RR; Murthy PB; Nguyen JK; McKenney J; Eng C; Campbell SC
    Urology; 2021 Feb; 148():113-117. PubMed ID: 33227300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?
    Mester JL; Moore RA; Eng C
    Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
    Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
    Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.
    Stanich PP; Pilarski R; Rock J; Frankel WL; El-Dika S; Meyer MM
    World J Gastroenterol; 2014 Feb; 20(7):1833-8. PubMed ID: 24587660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign goiters requiring thyroidectomy as the signal for PTEN hamartoma tumor syndrome diagnosis.
    Wang X; Moore C; Bao Y
    Am J Med Genet A; 2023 Mar; 191(3):753-759. PubMed ID: 36453251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.